Jenburkt Pharmaceuticals LtdBSE: JENBURPH

Jenburkt Pharmaceuticals Ltd Press Release Jan 13 2025

· Issued by Jenburkt Pharmaceuticals Ltd via BSE India

Filed with BSE ·

Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations, 2018, for the quarter ended on 31st December, 2024.

View Attachment

6ix hasn’t read this filing yet.

Jenburkt Pharmaceuticals Ltd on 6ix

Story so far

Earlier from Jenburkt Pharmaceuticals

Later from Jenburkt Pharmaceuticals

All Jenburkt Pharmaceuticals news releases